News Releases

This information is part of the archives and is no longer current and may no longer be accurate.

Keyword Search
 
2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010
DateTitle 
Dec 16, 2014DURECT Enters into License Agreement Granting Santen the Worldwide Rights to a Sustained Release SABER® Ophthalmology ProductPrinter Friendly Version
Dec 01, 2014DURECT to Present at the Oppenheimer Healthcare ConferencePrinter Friendly Version
Nov 11, 2014DURECT Provides Update on POSIDUR™ ProgramPrinter Friendly Version
Nov 03, 2014DURECT Corporation Announces Third Quarter 2014 Financial Results and Update of ProgramsPrinter Friendly Version
Oct 27, 2014DURECT Provides Update on REMOXY® and POSIDUR™ ProgramsPrinter Friendly Version
Oct 24, 2014DURECT Corporation Invites You to Join its Third Quarter 2014 Earnings Conference CallPrinter Friendly Version
Oct 10, 2014DURECT Announces POSIDUR™ (SABER®-Bupivacaine) Data Presentation at the American Society of Anesthesiologists Annual MeetingPrinter Friendly Version
Aug 25, 2014DURECT to Present at the Rodman & Renshaw Investment ConferencePrinter Friendly Version
Aug 07, 2014DURECT Corporation Announces Second Quarter 2014 Financial Results and Update of ProgramsPrinter Friendly Version
Jul 30, 2014DURECT Corporation Invites You to Join its Second Quarter 2014 Earnings Conference CallPrinter Friendly Version
Jun 26, 2014DURECT Secures $20 Million Debt FinancingPrinter Friendly Version
Jun 09, 2014DURECT to Present at The Wall Street Analyst Forum Institutional Investor ConferencePrinter Friendly Version
May 16, 2014DURECT Announces POSIDUR™ (SABER®-Bupivacaine) Data Presentation at the International Anesthesia Research Society (IARS) Annual MeetingPrinter Friendly Version
May 07, 2014DURECT Announces Participation in Bay Area Prescription Drug Abuse Summit MeetingPrinter Friendly Version
May 01, 2014DURECT Corporation Announces First Quarter 2014 Financial Results and Update of ProgramsPrinter Friendly Version
Apr 23, 2014DURECT Corporation Invites You to Join its First Quarter 2014 Earnings Conference CallPrinter Friendly Version
Apr 01, 2014DURECT Announces POSIDUR™ (SABER®-Bupivacaine) Data Presentations at the 39th Annual American Society of Regional Anesthetic and Pain Medicine MeetingPrinter Friendly Version
Feb 27, 2014DURECT Corporation Announces Fourth Quarter 2013 Financial Results and Update of ProgramsPrinter Friendly Version
Feb 18, 2014DURECT Corporation Invites You to Join its Fourth Quarter 2013 Earnings Conference Call and Upcoming Investor ConferencePrinter Friendly Version
Feb 12, 2014DURECT Receives Complete Response Letter from FDA for POSIDUR™ (SABER®-Bupivacaine)Printer Friendly Version
Jan 07, 2014Impax and DURECT Sign a $63 Million Agreement to Develop and Commercialize DURECT’s ELADUR® Pain PatchPrinter Friendly Version